Benha University Hospital, Egypt

Slides:



Advertisements
Similar presentations
What does sexual & reproductive health have to do with clinical trials? Providing contraception & reproductive health care helps.
Advertisements

CASE Mrs Ford is a 29 years old lady who has been complaining of vaginal discharge for the past 3 days. Otherwise she is asymptomatic. Her PMH includes.
URETHRAL DISCHARGE Treat for Gonorrhoea and Chlamydia 4 Cs:
Bacterial Vaginosis and Pregnancy : Clinical Overview and Public Health Implications Deborah B. Nelson, Ph.D. Assistant Professor Center for Clinical Epidemiology.
DIAGNOSIS AND TREATMENT OF VAGINITIS
Antibiotics Case Studies
UNM FM Journal Club A New Paradigm and Example July 16, 2014.
Laboratory Diagnosis of Vaginitis
Pelvic Inflammatory Disease (PID)
Vaginitis and PID – The Basics Wanda Ronner, M.D..
Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.
Vaginal Infections and Preterm Birth - An Update J. Chris Carey, MD Disponible en:
Behavioral and Demographic Risk Factors for Bacterial Vaginosis among Wyoming Women Presented by Jennifer Chase, MS 12 th Annual Maternal & Child Health.
Vaginitis and PID Wanda Ronner, M.D.. Vaginitis Disruption in the normal vaginal ecosystem Alteration of vaginal pH A decrease in lactobacilli Growth.
Candida infection Tricpmonas vaginalis Bacterial vaginosis
HIV and Reproduction Dr Felicia Molokoane Introduction 40 million people are living with HIV/AIDS SA is one of the fastest growing HIV epidemic.
Vaginal Discharge Jan 2014.
The laboratory investigation of urinary tract infections
F UNGAL G ENITOURINARY S YSTEM I NFECTIONS. Bladder and kidneys infections Valvovaginal infections.
Prof.Hanan Habib. To eradicate the offending organisms from the urinary bladder and tissues. The main treatment of UTI is by antibiotics.
Type 1 is responsible for most nongenital infections Type 2 HSV is recovered almost exclusively from the genital tract.
Pelvic inflammatory disease infection Involve - (PID) is a generic term for inflammation of the uterus( (endmetritis), fallopian tubes (salpingitis), and/or.
Sexually Transmitted Infections & HIV/AIDS
Multi-species Biofilms. Biofilms A biofilm is a community of microorganisms, associated with a surface, and encased in an extracellular polymeric matrix.A.
Copyright © 2006 Pearson Education, Inc., publishing as Benjamin Cummings Sexually Transmitted Diseases (STDs ); ch.16  Gonorrhea  Chlamydia  Syphilis.
Trichomonas Vaginalis
HPI A 23 year-old female comes to your office complaining of vaginal discharge, itching, and burning with urination for several days. The symptoms had.
Candida infection Tricpmonas vaginalis Bacterial vaginosis.
What’s Really Going on Down There?
Sexually Transimitted Diseases. Gonorrhea Cause –bacteria (Neisseria gonorrhoeae) Mode of transfer –Primary infection site is in cervix from intercourse.
Reproductive block Objectives Name various etiological agents causing sexually transmitted diseases (STD) Describe the clinical presentations.
Wet Mount PT: 2007A Specimen 1 Evaluate micrographs 1-a, 1-b, 1-c and 1-d together as if different fields from the same patient Identify cellular images.
Syndromes.
Epidemiology of STD. Change in incidence (simple access to antibiotic, change to sexual behavior, multiple partner, low age of sexual contact, addiction,
Bacterial Vaginosis By Scott Ecker. What is bacterial vaginosis  It is the name of a condition in women where the normal in women where the normal balance.
GENITAL TRACT INFECTION Lower GTI At birth the vagina is lined by stratified sq.epith.under the influnce of maternal oestrogen. This lining is changed.
INTRODUCTION TO SYNDROMIC MANAGEMENT OF STIs
Sexually Transmitted Infections Jeannie Harper, PhD, RN.
What is pelvic inflammatory disease (PID)? Pelvic inflammatory disease (PID) is an infection in the female reproductive organs. Normally, the cervix prevents.
New standard in Vaginitis treatment
Pelvic Inflammatory Disease Darleny Rivas and Emyah Crisostomo Senior Health 12 Block: 2B March 2016.
Vaginal discharge culture
Michael Addidle Bacterial Vaginosis. What is Bacterial Vaginosis (BV) ? Polymicrobial vaginal infection involving a reduction in the amount of Lactobacilli.
Gonorrhea STD Science Fair Project Group Members: Tiffany Jackson, Rachel Roessel, Siobhan Murphy.
Clinical Assessment of the Vagina
Vaginal Infections NURS 541: Women’s Healthcare – Diagnosis and Management.
Pelvic Inflammatory Disease / Pelvic Abscess
Trichomonas vaginalis
Trichomonas Vaginalis
Name of Disease: Vaginitis
GENITAL TRACT INFECTION
Hypothyroidism during pregnancy
TRICHOMONAS VAGINALIS.
Gonorrhoea & PID PHCP 402 By K S Labaran.
Management of Urinary Tract Infections Renal Block
Management of Urinary Tract Infections Renal Block
Dr.Jyothi Ranganathan Head lab operations SRL Ltd Bangalore
LECTURE TOPIC: VAGINITIS
Sexually Transmitted Infections
Morning Report January 31, 2011.
Risks for Bacterial Vaginosis in Lesbian & Bisexual Women
Sexually Transimitted Diseases
Non-Viral STD of Major significance
SEXUALLY TRANSMITTED DISEASES
postoperativeinfections
Pelvic inflammatory disease infection Involve
Test Slide Douglas Ong.
Special Issues of Women’s Health Care and Reproduction
Thrombophilia in pregnancy: Whom to screen, when to treat
Presentation transcript:

Benha University Hospital, Egypt Bacterial vaginosis Benha University Hospital, Egypt www.ppttopics.com

Anaerobic vaginosis: Gardnerella vaginalis & anaerobic bacteria Non-specific vaginitis: Haemophilus vaginalis Gardnerella vaginitis: Gardnerella vaginalis Anaerobic vaginosis: Gardnerella vaginalis & anaerobic bacteria Bacterial vaginosis: polymicrobial alteration in vaginal flora causing an increase in vaginal pH, sometimes associated with an homogenous discharge, but in the absence of a demonstrable inflammatory response (Eschenbach et al, 1988) History www.ppttopics.com

BV is the most common cause of vaginal discharge in young women of reproductive age. Prevalence between 5% & 35% depends on method of screening & the locality. Prevalence www.ppttopics.com

G. vaginalis (coccobacilli, surface pathogen), Polymicrobial: G. vaginalis (coccobacilli, surface pathogen), Anaerobic bacteria (Bacteroids, Mobiluncus, Prevotella) & Mycoplasma hominis. There is synergistic relationship between the acquired organisms. They replace lactobacilli Aetiology www.ppttopics.com

Mobiluncus produce trimethylamine giving the smell of rotting fish. Their metabolism produces volatile amines & organic acids other than lactic acids leading to smell & increase pH. Mobiluncus produce trimethylamine giving the smell of rotting fish. Mobiluncus & Bacteroids produce succinate (Keto-acid) which raises vaginal pH. Absence of lactic acid & the production of succinate blunt the chemotactic response of polymorphnuclear leukocytes & reduce their killing ability. This explains absence of cellular inflammatory response. www.ppttopics.com

b= bacteroids, c= mobilincus, g= gardenerlla, p=peptostreptococci Gram stain b= bacteroids, c= mobilincus, g= gardenerlla, p=peptostreptococci www.ppttopics.com

Electron micrograph of Mobiluncus www.ppttopics.com

after menstruation when estradiol levels increase. 1. Increase vaginal pH: Semen, after menstruation when estradiol levels increase. 2. Decrease lactobacilli: Douching, change of sexual partner (change of vaginal environment), episodes of candida . Predisposing factors www.ppttopics.com

3. Smoking: suppresses the immune system facilitating infection. 4. IUCD: 5. Black ethnic groups 6. Lesbians It is not STD: Treatment of the husband is not beneficial in preventing recurrence of BV. Detection of BV in 12% of virgins after menarche. www.ppttopics.com

The reason for the alteration in flora is unclear. 1.Hormonal changes: the mechanism is unclear 2.Enzymatic changes: Mucinase & siallidase are elevated in vaginal discharge of BV. Breaking down the mucosal barrier 3.Bacteriophage ( virus that infects bacteria) Pathogenesis www.ppttopics.com

Up to half the women diagnosed with BV are asymptomatic. .Discharge: thin, homogenous, whitish-grey, frothy & fishy. Absence of discharge does not imply the absence of BV. It is not accepted as a reliable indicator on its own as it is neither sensitive nor specific to BV.(Deborah et al,2003) .Seldom associated with mucosal inflammation or irritation of the vagina or vulval itch. Clinical picture www.ppttopics.com

1.pH of discharge: 5.7 A low pH virtually excludes BV. An elevated pH is the most sensitive but least specific as an increase can also associated with menstruation, recent sexual intercourse, or infection with T. vaginalis Diagnosis www.ppttopics.com

2.Whiff test (amine test). Addition of 10% KOH to a sample of vaginal discharge produces fishy odor. It has a positive predictive value of 90% & specificity of 70% www.ppttopics.com

3.Wet film (drop of vaginal secretion & drop of saline): clue cells (epithelial cells covered by coccobacilli, borders are indistinct), No WBC. It is the single most sensitive & specific criterion for BV. , but it is operator dependent. Debris & degenerated cells may be mistaken for clue cells & lactobacilli may adhere to epithelial cells in low numbers. . www.ppttopics.com

4. Gram stain: 90% sensitivity, highly sensitive & specific (Gr. Variable c.bacilli, no WBC, no lactobacilli). Scoring systems which weight numbers of lactobacilli & numbers of G vaginalis & Mobiluncus. It is simple & objective method. However the cost & need for microscopist. . www.ppttopics.com

.Diamine test: rapid, sensitive & specific 5.Rapid tests: .Diamine test: rapid, sensitive & specific .Proline aminopeptidase test (Pip Activity test Card) .A card test for detection of elevated pH & trimethylamine (FemExam test card) .DNA probe based test for high concentration of G. vaginalis (Affirm VP III) may have clinical utility. www.ppttopics.com

. Pap. smear: clue cells. Limited clinical utility because of low sensitivity .Culture: It is not recommended as a diagnostic tools because it is not specific. www.ppttopics.com

Amsel’s criteria 3 of the following: .Homogenous discharge. .pH> 4.5. . Amine test. .Clue cells. Gram stain alone corresponds well to Amsel’s criteria & to the presence of the associated bacteria. www.ppttopics.com

Gynecological 1. Psychological disturbance 2. PID: The microorganisms of BV & PID are similar. There is 10 fold-increased risk of PID in females with BV. 3. Tubal infertility: 1/3 of women with tubal factor infertility had BV compared to 16% of male factor infertility (Wilson et al, 2000). Complications www.ppttopics.com

4. Post-hysterectomy vaginal cuff infection. 5. Uretheral syndrome. 6. HIV susceptibility infection. The presence of BV increases susceptibility to HIV infection BV is not associated with CIN www.ppttopics.com

Obstetric 1. Miscarriage: Women with BV had a higher rate of first trimester miscarriage than those with normal vaginal flora. Recurrent first trimester miscarriage has not been associated with BV. The incidence of late miscarriage (13-23 w) is higher in women with BV. 2. Postabortal sepsis. The use of antibiotic prophylaxis before surgical termination of pregnancy demonstrates a protective effect. www.ppttopics.com

4.Bactraemia after instrumental delivery 6.Chorioamnionitis. 3.Preterm labour. The earlier in pregnancy that BV is detected the greater the risk of PTL. Treatment of high risk, BV positive pregnant women has resulted in reduction of PTL by 40-50%. 4.Bactraemia after instrumental delivery 6.Chorioamnionitis. 7.Postpartum endometritis, post cesarean wound infection www.ppttopics.com

A. Non pregnant Treatment Benefits of treatment: . relieve vaginal symptoms & signs of infection. . Reduce the risk for infectious complications after hysterectomy or abortion. . Reduction of other infectious complications e.g., HIV, STD Indications 1. Symptomatic women (Grade A recommendation). 2. Women undergoing some surgical procedures(Grade A recommendation). Treatment www.ppttopics.com

Recommended regimens (CDC,2002) Metronidazole 500 mg orally twice a day for 7 days, OR Metronidazole gel 0.75%, one full applicator (5g) intravaginally, once a day for 5 days OR Clindamycin cream 2%, one full applicator (5g) intravaginally at bed time for 7 days. www.ppttopics.com

Alternative regimens (CDC,2002) Metronidazole 2 g orally in a single dose, OR Clindamycin 300 mg orally twice a day for 7 days, OR Clindamycin ovules 100 mg intravaginally once at bedtime for 3 days. www.ppttopics.com

The alternative regimens have lower efficacy for BV. Notes: The recommended metronidazole regimens are equally effective. Metronidazole gel is more expensive than tablets The vaginal clindamycin is less effective than the metronidazole regimens. The alternative regimens have lower efficacy for BV. No data support the use of non-vaginal lactobacilli or douching for treatment of BV. www.ppttopics.com

Clindamycin cream or oral is preferred in case of allergy or intolerance to metronidazole. Theoretically, Metronidazole has an advantage because it is less active against lactobacilli than clindamycin. Conversely, clindamycin is more active than metronidazole against most of the bacteria associated with bacterial vaginosis www.ppttopics.com

Follow-up visits are unnecessary if symptoms resolve. Another recommended treatment regimen may be used to treat recurrent disease. Management of husband is not recommended www.ppttopics.com

The majority is asymptomatic. B. Pregnant Natural history: BV is present in up to 20% of pregnant women depending on how often the population is screened. The majority is asymptomatic. It may spontaneously resolve without treatment, although the majority is likely to have persistent infection later in pregnancy. www.ppttopics.com

Metronidazole 250 mg orally three times a day for 7 days, OR Recommended regimen Metronidazole 250 mg orally three times a day for 7 days, OR Clindamycin 300 mg orally twice a day for 7 days www.ppttopics.com

Notes: Existing data do not support the use of topical agents during pregnancy. Evidence from three trials suggests an increase in adverse events (e.g. prematurity & neonatal infection), particularly in newborns, after use of clindamycin cream (McGregor et al,1994; Joesoef et al,1995; Vermeulen et al,1999). www.ppttopics.com

Multiple studies & meta-analysis have not demonstrated a consistent association between metronidazole during pregnancy & teratogenic or mutagenic effects in newborns (Caro-Paton et al,1997). www.ppttopics.com

1. All symptomatic pregnant women should be tested & treated. Indications 1. All symptomatic pregnant women should be tested & treated. 2. Asymptomatic pregnant women at high risk for PTL ( previous history), should be screened early in pregnancy & treated (Cochrane library,2002) www.ppttopics.com

3. Asymptomatic pregnant females at low risk for PTL: Data are conflicting whether treatment reduces adverse outcomes of pregnancy. One trial, using oral clindamycin demonstrated a reduction in PTL & postpartum infectious complications (Hay et al, 2001). Oral clindamycin early in the second trimester significantly reduced the rate of late miscarriage & PTL in general obstetric population (Ugwumadu et al, 2003). www.ppttopics.com

How to screen for BV ? (Gierdingen et al, 2000) Ask about symptoms & pH of the vagina is determined frequently during pregnancy. If pH > 4.5 ( BV or TV in 84%), do wet mount. Follow-up of pregnant women One month after treatment to evaluate whether therapy was effective is recommended. www.ppttopics.com

C. lactation Metronidazole enters breast milk & may affect its taste. The manufacturer recommend avoiding high doses if breast feeding. Small amounts of clindamycin enter breast milk. It is prudent therefore to use an intravaginal treatment for lactating women (Grade C recommendation) www.ppttopics.com

Benha University Hospital, Egypt Thank you Benha University Hospital, Egypt www.ppttopics.com